This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Feb 11;379(9815):498-500.

doi: 10.1016/S0140-6736(11)61929-6. Epub 2012 Jan 10.

Improving Alzheimer's disease outcomes in Down's syndrome

Gill Livingston¹, Andre Strydom

Affiliations

PMID: 22236803
DOI: 10.1016/S0140-6736(11)61929-6

Comment

Improving Alzheimer's disease outcomes in Down's syndrome

Gill Livingston et al. Lancet. 2012.

. 2012 Feb 11;379(9815):498-500.

doi: 10.1016/S0140-6736(11)61929-6. Epub 2012 Jan 10.

Authors

Gill Livingston¹, Andre Strydom

Affiliation

¹ Unit of Mental Health Sciences, University College London, London W1W 7EJ, UK. G.Livingston@ucl.ac.uk

PMID: 22236803
DOI: 10.1016/S0140-6736(11)61929-6

No abstract available

PubMed Disclaimer

Comment on

Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial.
Hanney M, Prasher V, Williams N, Jones EL, Aarsland D, Corbett A, Lawrence D, Yu LM, Tyrer S, Francis PT, Johnson T, Bullock R, Ballard C; MEADOWS trial researchers. Hanney M, et al. Lancet. 2012 Feb 11;379(9815):528-36. doi: 10.1016/S0140-6736(11)61676-0. Epub 2012 Jan 10. Lancet. 2012. PMID: 22236802 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information